• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质类固醇治疗改善自身免疫性肝炎诱导的急性肝衰竭的预后。

Corticosteroid Therapy Improves the Outcome of Autoimmune Hepatitis-Induced Acute Liver Failure.

机构信息

Department of Gastroenterology and Hepatology, University Hospital, University of Duisburg Essen, Essen, Germany.

Department of Gastroenterology and Hepatology, University Hospital, University of Magdeburg, Magdeburg, Germany.

出版信息

Digestion. 2018;98(2):104-111. doi: 10.1159/000487940. Epub 2018 Apr 26.

DOI:10.1159/000487940
PMID:29698940
Abstract

BACKGROUND/AIMS: Autoimmune hepatitis (AIH) is a relatively rare cause of liver dysfunction and may lead in some cases to acute liver failure (ALF). The aim of our study was to evaluate the clinical course and outcome of patients with AIH-induced ALF.

METHODS

We retrospectively enrolled 32 patients with AIH-induced ALF and 93 age- and sex-matched patients with chronic AIH (cAIH) who were enrolled at the University Clinic Essen from 1988 to 2014. All ALF patients were treated with corticosteroids after diagnosis.

RESULTS

Overweight, higher γ-globulin levels, the absence of anti-smooth muscle antibodies and human leukocyte antigen (HLA) B8 and the presence of anti-mitochondrial antibodies and HLA DR7 were risk factors for an ALF vs chronic hepatitis manifestation of AIH. Liver histology was significantly more often typical for AIH in an ALF setting than in cAIH. The spontaneous survival rate was 91% and 97% in ALF and cAIH patients, respectively, at 6 months after diagnosis and only 1 patient in the ALF group developed sepsis under therapy.

CONCLUSION

Liver biopsy in an AIH-mediated ALF setting was both safe and effective in diagnosing AIH. Corticosteroid therapy was not associated with high mortality or sepsis. Our findings suggest that corticosteroid treatment of AIH-mediated ALF may improve the outcome.

摘要

背景/目的:自身免疫性肝炎(AIH)是一种相对罕见的肝功能障碍病因,在某些情况下可能导致急性肝衰竭(ALF)。我们的研究目的是评估 AIH 诱导的 ALF 患者的临床过程和结局。

方法

我们回顾性纳入了 32 名 AIH 诱导的 ALF 患者和 93 名年龄和性别匹配的慢性 AIH(cAIH)患者,这些患者于 1988 年至 2014 年在埃森大学诊所就诊。所有 ALF 患者在诊断后均接受皮质类固醇治疗。

结果

超重、γ-球蛋白水平较高、缺乏抗平滑肌抗体和人类白细胞抗原(HLA)B8,以及存在抗线粒体抗体和 HLA DR7,是 AIH 发生 ALF 与慢性肝炎表现的危险因素。与 cAIH 相比,ALF 时肝组织学更常表现为典型的 AIH。诊断后 6 个月,ALF 和 cAIH 患者的自发存活率分别为 91%和 97%,仅有 1 例 ALF 患者在治疗期间发生脓毒症。

结论

在 AIH 介导的 ALF 中进行肝活检在诊断 AIH 方面既安全又有效。皮质类固醇治疗与高死亡率或脓毒症无关。我们的研究结果表明,皮质类固醇治疗 AIH 介导的 ALF 可能改善结局。

相似文献

1
Corticosteroid Therapy Improves the Outcome of Autoimmune Hepatitis-Induced Acute Liver Failure.皮质类固醇治疗改善自身免疫性肝炎诱导的急性肝衰竭的预后。
Digestion. 2018;98(2):104-111. doi: 10.1159/000487940. Epub 2018 Apr 26.
2
Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients.潜在的急性肝衰竭触发因素作为自身免疫性肝炎的首发表现:52 例成人患者的单中心经验。
World J Gastroenterol. 2018 Apr 7;24(13):1410-1418. doi: 10.3748/wjg.v24.i13.1410.
3
Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score.早期肝移植治疗对皮质类固醇无反应的急性重症自身免疫性肝炎:SURFASA 评分。
J Hepatol. 2021 Jun;74(6):1325-1334. doi: 10.1016/j.jhep.2020.12.033. Epub 2021 Jan 24.
4
Acute onset of autoimmune hepatitis in children and adolescents.儿童和青少年自身免疫性肝炎的急性发作。
Hepatobiliary Pancreat Dis Int. 2020 Feb;19(1):17-21. doi: 10.1016/j.hbpd.2019.08.004. Epub 2019 Aug 24.
5
Clinical characteristics and treatment outcomes of acute severe autoimmune hepatitis.急性重症自身免疫性肝炎的临床特征与治疗结果
BMC Gastroenterol. 2021 Mar 1;21(1):93. doi: 10.1186/s12876-021-01653-4.
6
Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.皮质类固醇对自身免疫性肝炎严重和暴发性形式的治疗作用。
Liver Transpl. 2007 Jul;13(7):996-1003. doi: 10.1002/lt.21036.
7
Outcomes and management in paediatric autoimmune hepatitis presenting as acute liver failure: Individual patient data meta-analysis.儿科自身免疫性肝炎表现为急性肝衰竭的结局和管理:个体患者数据分析荟萃分析。
Liver Int. 2024 Aug;44(8):1797-1807. doi: 10.1111/liv.15943. Epub 2024 May 3.
8
Acute presentation of autoimmune hepatitis -from acute hepatitis to ALF and ACLF.自身免疫性肝炎的急性表现——从急性肝炎到急性肝衰竭和慢加急性肝衰竭。
Hepatol Int. 2024 Oct;18(5):1385-1395. doi: 10.1007/s12072-024-10714-1. Epub 2024 Aug 11.
9
Steroid use in acute liver failure.急性肝衰竭中的类固醇使用。
Hepatology. 2014 Feb;59(2):612-21. doi: 10.1002/hep.26678. Epub 2013 Dec 24.
10
Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis.严重型急性1型自身免疫性肝炎的临床病理特征
Clin Gastroenterol Hepatol. 2007 Feb;5(2):255-8. doi: 10.1016/j.cgh.2006.10.011. Epub 2007 Jan 9.

引用本文的文献

1
Acute presentation of autoimmune hepatitis -from acute hepatitis to ALF and ACLF.自身免疫性肝炎的急性表现——从急性肝炎到急性肝衰竭和慢加急性肝衰竭。
Hepatol Int. 2024 Oct;18(5):1385-1395. doi: 10.1007/s12072-024-10714-1. Epub 2024 Aug 11.
2
Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.循环受体相互作用蛋白激酶 3 水平作为急性肝损伤标志物的潜力。
Sci Rep. 2023 Aug 28;13(1):14043. doi: 10.1038/s41598-023-41425-6.
3
HLA, gut microbiome and hepatic autoimmunity.HLA、肠道微生物组与肝自身免疫。
Front Immunol. 2022 Aug 18;13:980768. doi: 10.3389/fimmu.2022.980768. eCollection 2022.
4
Glucocorticoid Treatment Strategies in Liver Failure.糖皮质激素在肝衰竭中的治疗策略。
Front Immunol. 2022 Mar 16;13:846091. doi: 10.3389/fimmu.2022.846091. eCollection 2022.
5
LR12 Promotes Liver Repair by Improving the Resolution of Inflammation and Liver Regeneration in Mice with Thioacetamide- (TAA-) Induced Acute Liver Failure.LR12 通过改善硫代乙酰胺 (TAA) 诱导的急性肝衰竭小鼠的炎症消退和肝再生来促进肝脏修复。
Mediators Inflamm. 2021 May 28;2021:2327721. doi: 10.1155/2021/2327721. eCollection 2021.
6
Clinical characteristics and treatment outcomes of acute severe autoimmune hepatitis.急性重症自身免疫性肝炎的临床特征与治疗结果
BMC Gastroenterol. 2021 Mar 1;21(1):93. doi: 10.1186/s12876-021-01653-4.
7
Early Predictors of Short-Term Prognosis in Acute and Acute Severe Autoimmune Hepatitis.急性和急性重症自身免疫性肝炎短期预后的早期预测指标。
Liver Transpl. 2020 Dec;26(12):1573-1581. doi: 10.1002/lt.25906. Epub 2020 Oct 27.
8
Approach to the patient with acute severe autoimmune hepatitis.急性重症自身免疫性肝炎患者的诊疗方法
JHEP Rep. 2020 Jul 21;2(6):100149. doi: 10.1016/j.jhepr.2020.100149. eCollection 2020 Dec.
9
Autoimmune Hepatitis: 2019 Update.自身免疫性肝炎:2019 更新版。
Gut Liver. 2020 Jul 15;14(4):430-438. doi: 10.5009/gnl19261.